A variety of factors influence treatments of COVID-19.
作者信息
Hu Caihong, Huang Yi, Zhang Weishe, Zhu Jiahao, Fei Kuilin, Li Qi, Huang Jingrui
机构信息
Department of Obstetrics, Xiangya Hospital Central South University.
Hunan Engineering Research Center of Early Life Development and Disease Prevention.
出版信息
Gac Med Mex. 2023;159(4):356-357. doi: 10.24875/GMM.23000146.
PMID:37699208
Abstract
摘要
相似文献
1
A variety of factors influence treatments of COVID-19.
Gac Med Mex. 2023;159(4):356-357. doi: 10.24875/GMM.23000146.
2
Mesenchymal stem cell therapies for COVID-19: Current status and mechanism of action.用于治疗新冠肺炎的间充质干细胞疗法：现状与作用机制
Life Sci. 2020 Dec 1;262:118493. doi: 10.1016/j.lfs.2020.118493. Epub 2020 Sep 23.
3
The role of mesenchymal stem cells in COVID-19 treatment.间充质干细胞在新冠病毒肺炎治疗中的作用。
Tuberk Toraks. 2020 Dec;68(4):430-436. doi: 10.5578/tt.69770.
4
[Experimental treatments and Coronavirus].
Rev Med Chil. 2020 May;148(5):571-572. doi: 10.4067/S0034-98872020000500571.
5
COVID-19 outbreak and vascular surgery treatments: experiences, evidence, perspective.2019冠状病毒病疫情与血管外科治疗：经验、证据、展望
J Cardiovasc Surg (Torino). 2021 Dec;62(6):525-526. doi: 10.23736/S0021-9509.21.12114-7. Epub 2021 Sep 30.
6
In September 2020, the World Health Organization called for 'equitable access to COVID-19 tools' which included 'the development, production and equitable access to COVID-19 tests, treatments and vaccines globally, while strengthening health systems'. What evidence is there of inequity of access so far in this pandemic? What is the role of national governments and of the WHO in this?2020年9月，世界卫生组织呼吁“公平获取新冠病毒工具”，其中包括“在全球范围内研发、生产并公平获取新冠病毒检测手段、治疗方法和疫苗，同时加强卫生系统”。在这场大流行中，到目前为止有哪些获取方面不公平的证据？各国政府和世界卫生组织在此过程中分别扮演什么角色？
Med Confl Surviv. 2021 Sep;37(3):187-196. doi: 10.1080/13623699.2021.1969879.
7
Clinical Trials of COVID-19 Therapies Should Account for Diabetes and Hyperglycemia.新冠病毒治疗的临床试验应考虑糖尿病和高血糖因素。
J Diabetes Sci Technol. 2021 Sep;15(5):1181-1187. doi: 10.1177/19322968211013369. Epub 2021 Jun 23.
8
In September 2020, the World Health Organization called for 'equitable access to COVID-19 tools' which included 'the development, production and equitable access to COVID-19 tests, treatments and vaccines globally, while strengthening health systems'. What evidence is there of inequity of access so far in this pandemic? What is the role of national governments and of the WHO in this?2020年9月，世界卫生组织呼吁“公平获取新冠疫情相关工具”，其中包括“在全球范围内研发、生产并公平获取新冠病毒检测手段、治疗方法和疫苗，同时加强卫生系统”。在这场大流行中，到目前为止有哪些获取方面不公平的证据？各国政府和世卫组织在此过程中分别扮演什么角色？
Med Confl Surviv. 2021 Sep;37(3):197-204. doi: 10.1080/13623699.2021.1969878. Epub 2021 Aug 25.
9
COVID-19 Treatments for Nonhospitalized Patients.非住院患者的新冠病毒病治疗方法
JAMA. 2022 Jun 14;327(22):2247. doi: 10.1001/jama.2022.6167.
10
COVID-19 Treatments for Nonhospitalized Patients.非住院患者的新冠病毒病治疗方法
JAMA. 2022 Jun 14;327(22):2248. doi: 10.1001/jama.2022.6170.
Zotero 插件